Sugawara-Mikami M, Tanigawa K, Kawashima A, et al. Pathogenicity and virulence of Mycobacterium leprae. Virulence. 2022;13
(1):1985–2011....
LAR Froes, Junior Sotto MN, MAB Trindade. Leprosy: clinical
and immunopathological characteristics. An Bras Dermatol.
2022;97(3):338–347....
Uaska Sartori PV, Penna GO, Bührer-Sékula S, et al. Human
genetic susceptibility of leprosy recurrence. Sci Rep. 2020;10(1).
https://doi.org/10.1038/s41598-020-58079-3.
Polycarpou A, Walker SL, Lockwood DNJ. A systematic review of
immunological studies of erythema nodosum leprosum. Front
Immunol. 2017;8. https://doi.org/10.3389/fimmu.2017.00233.
Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, et al.
Erythema nodosum: a practical approach and diagnostic
algorithm. Am J Clin Dermatol....
Park L, Wallace CE, Vasile G, et al. A case of lepromatous
leprosy with erythema nodosum leprosum. Cureus. 2023;15(1).
https://doi.org/10.7759/cureus.33846.
Stefani MMA, Avanzi C, Bührer-Sékula S, et al. Whole genome
sequencing distinguishes between relapse and reinfection in
recurrent leprosy...
Montaño GS, Lancheros González PC. Celis L.G.Recidiva de lepra
y reacción tipo II en paciente tratado con poliquimioterapia
(PQT). Nova. 2014;12(21):109–114.
P K Mishra SR, Samal R, Behera B. Thalidomide and steroid in the
management of erythema nodosum leprosum. Indian J Pharm.
2022;54(3):177–182....
